Loading…
Blackbaud, Inc.
NASDAQ: BLKB Technology IT 🔎 Screen
🏹 Trader: 📈 Stage 2 View all →
📈 Stage 2 detected Find the fundamental catalyst → → run Growth Triggers in Ask AI
$2.3B
Market Cap
26.7
P/E
1.66
PEG
14.3%
ROCE
108.5%
ROE
12.83
D/E
16.9%
OPM
-32.9%
% from 52W High
73
α RS
🔍 BLKB is showing a notable setup because RS Rating is 73 and an ECS of 60.1 last quarter. Net: Partial signal stack, not a recommendation. ? RS Rating ECS
Sources
RS Rating 73 · ECS 60.1
⚖️ Compare 🔒 Generate Report 🔒 Research Packet 📚 Guides
🌏 Global Investor Returns
Currency-adjusted total returns for BLKB including FX impact
🌏
Click 🌏 Returns tab to load data
📈 Price History
Ratio Health
Excellent
Good
Average
Poor
By Category
📊 Sector Averages
About

Blackbaud, Inc. engages in the providing AI-powered solutions in the United States and internationally.

Key Ratios Snapshot
📈 Growth Pattern
📊 Quick Scorecard
Loading…
⭐ Superinvestors Holding BLKB
View All Superinvestors →
Manager Shares Value % of Fund Period
Steve Cohen Point72 Asset Management 160.6K $6.2M 0.01% Mar 2026
Jim Simons Renaissance Technologies LLC 35.0K $1.4M 0.00% Mar 2026

SEC Form 13F data. 45-day lag from quarter end.

🔒
Premium Feature
AI-generated 10-section company profile — business model, financials, strengths, risks & management quality
Upgrade to Premium
Already a member? Log in
📐
3-Statement Financial Model
Bear / Base / Bull projections · DCF fair value · Reverse-DCF
Open Model →
📊 MIXED Blackbaud Q1 2026: 4.2% organic revenue growth to $281M, non-GAAP EPS up 20% to $1.14, launches first AI agent
Revenue & Profitability
For Q1 2026, Blackbaud reported organic revenue growth of 4.2% to $281 million. Non-GAAP adjusted EBITDA was $99 million, up $7 million year-over-year, with a ~1 percentage point margin improvement. Non-GAAP EPS increased 20% to $1.14. Free cash flow was $37 million, up nearly $50 million from the prior year. The company reaffirmed its full-year 2026 guidance ranges.
Outlook
Management sees continued demand for mission-critical solutions in the social impact sector, noting that many customers face IT resource constraints and staffing shortages. They view AI as a key enabler for customers to improve engagement and fundraising efficiency. The company does not assume any viral giving events in its guidance and acknowledges that transactional revenue can be variable quarter-to-quarter.
Growth Drivers
Key growth levers include new product launches, particularly the Agents for Good category, with the first agent (Fundraising Development Agent) now commercially available. Cross-selling to existing customers (back-to-base) and winning new logos in verticals like K-12, nonprofits, and corporate giving (YourCause) are central. The company also closed one of its largest-ever enterprise deals in Q1 with a long-term contract.
Balance Sheet & CapEx
Not specifically discussed in the call. However, management noted planned AI investments in Q2 2026, which will cause adjusted EBITDA dollars to decline slightly year-over-year in that quarter. Investments include tools from Anthropic and other vendors, as well as building internal agents for engineering productivity. Free cash flow is expected to grow significantly, with at least 50% of cumulative free cash flow from 2026-2030 allocated to share repurchases.
Margins
Q1 2026 adjusted EBITDA margin improved by approximately 1 percentage point year-over-year. Longer-term, the company targets adjusted EBITDA margin expansion to 40%+ (from current levels). Gross margin improvement is expected from closing two remaining legacy data centers and reducing reliance on legacy vendor infrastructure. Q2 2026 EBITDA dollars are expected to be slightly down year-over-year due to planned AI investments.
Key Risks
Management flagged that transactional revenue can vary quarter-to-quarter and that guidance does not assume any viral giving events. The Q2 2026 EBITDA decline due to AI investments was noted as a near-term risk. Other risks discussed in the transcript include customer IT resource constraints and staffing shortages, though these also represent opportunities. No additional risks were explicitly raised by analysts.
Generated by AI · Q1 2026 results · Not investment advice
🔒
Free Account Required

Create a free Finmagine account to access Finmagine™ Scorecard.

See how this company scores across 5 dimensions — Financial Health, Growth Prospects, Competitive Position, Management Quality, and Valuation — powered by 30+ computed ratios.

Create Free AccountLog In
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Ask AI.

Get 25 expert AI analysis templates — Business KPIs, Comprehensive, Forensic Governance, Peer Comparison, Risk-Reward, Full Research Report, IPO Decoder, Red Flag Detector, and more — ready to paste into ChatGPT, Claude, Gemini, or Perplexity.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Peer Comparison.

Compare this company side-by-side against its sector peers with financial metrics, ratio benchmarking, and relative performance across all key dimensions.

Upgrade to PremiumCreate Free Account
✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter
🔍
🔎 See cross-company document search → ?
📞 Earnings Call Transcripts (5)
Q2 2026 Q2 2026 2026-07-29
Q2 2026 saw 3% organic revenue growth, 9% EPS growth, and strong free cash flow, with performance tracking to the high end of guidance. AI innovation accelerated, driving new customer wins and longer contract terms, while a new platform fee and continued stock repurchases support future growth.
Q1 2026 Q1 2026 2026-04-29
Q1 2026 saw 4.2% organic revenue growth, 20% non-GAAP EPS growth, and strong free cash flow, driven by AI innovation and new product launches. Full-year guidance is reaffirmed, with double-digit EPS growth targeted and significant capital allocated to share repurchases.
Q4 2025 Q4 2025 2026-02-10
Achieved strong 2025 results with 5.5% organic revenue growth, margin expansion, and robust free cash flow. 2026 guidance projects continued growth, with new AI-driven products offering future upside not yet included in forecasts.
Q3 2025 Q3 2025 2025-10-29
Q3 saw 5.2% organic revenue growth, 11% EPS growth, and strong free cash flow, driven by operational discipline, innovation, and robust transactional platforms. Guidance for 2025 remains strong, with increased free cash flow and continued stock repurchases prioritized.
Q2 2025 Q2 2025 2025-07-30
Q2 2025 saw record revenue, margin, and EPS growth, driven by strong transactional performance, innovation in AI, and new customer wins. Full-year guidance was raised across all metrics, with continued focus on operational discipline, capital returns, and product leadership.
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Catalyst Timeline.

Every result, order win, insider trade, ECS update, earnings-call, and SEC announcement for this company — in one chronological lane.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Full Report.

Read the complete Finmagine™ investment research report — comprehensive fundamental analysis, business model assessment, competitive positioning, and investment recommendation.

Upgrade to PremiumCreate Free Account

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯
Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.
📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

Financial Model
Projections are built from each company's audited annual financials (Income Statement, Balance Sheet, Cash Flow) over the last 5 fiscal years. Forward assumptions — revenue growth %, EBITDA margin, D&A (USD millions), interest expense, tax rate, and capex — are AI-generated using historical context and refreshed twice a year: after the December results season and after the September/Q4 results season.

DCF Valuation
Fair Value = Σ(FCFt / (1+WACC)t) + Terminal Value. Terminal Value uses the Gordon Growth Model: FCF5 × (1+g) / (WACC−g). Default WACC: 10% (US risk-free ~4.5%, equity risk premium ~5.5%). Default terminal growth: 3% (long-run US nominal GDP proxy).

CAGR Tracker
Expected 5-year CAGR = (DCF Fair Value / Current Price)1/5 − 1. Assumes fair value is reached in exactly 5 years — a mechanical estimate only.

Data Sources & Limitations
Financial statements sourced from public filings. Prices updated daily. Forward assumptions are AI-generated. All monetary values in USD millions. Non-US ADR companies may have currency conversion inaccuracies. Models are point-in-time and do not update intra-quarter or account for M&A, macro shocks, or extraordinary items.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.